home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/c6232792-e999-47d1-b9e2-e3521fb48570_Pharmacovigilance Rare Disease Gene Therapies White Paper.pdf
whitepaper
PHARMACOVIGILANCE AND RISK MANAGEMENT CONSIDERATION FOR RARE DISEASE GENE THERAPIES
The development of a pharmacovigilance and risk management system to support a gene therapy for a rare genetic disease requires consideration of the specific challenges and nuances that novel therapies present throughout the lifetime of the product. DOWNLOAD